BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1318172)

  • 1. Embryonic lesions of the substantia nigra prevent the patchy expression of opiate receptors, but not the segregation of patch and matrix compartment neurons, in the developing rat striatum.
    van der Kooy D; Fishell G
    Brain Res Dev Brain Res; 1992 Mar; 66(1):141-5. PubMed ID: 1318172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of a patchy organization of the rat striatum.
    Lança AJ; Boyd S; Kolb BE; van der Kooy D
    Brain Res; 1986 Jun; 392(1-2):1-10. PubMed ID: 3011213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern formation in the mammalian forebrain: striatal patch and matrix neurons intermix prior to compartment formation.
    Krushel LA; Fishell G; van der Kooy D
    Eur J Neurosci; 1995 Jun; 7(6):1210-9. PubMed ID: 7582094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern formation in the striatum: neurons with early projections to the substantia nigra survive the cell death period.
    Fishell G; van der Kooy D
    J Comp Neurol; 1991 Oct; 312(1):33-42. PubMed ID: 1660493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern formation in the striatum: developmental changes in the distribution of striatonigral neurons.
    Fishell G; van der Kooy D
    J Neurosci; 1987 Jul; 7(7):1969-78. PubMed ID: 2886562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential maturation of cholinergic interneurons in the striatal patch versus matrix compartments.
    Van Vulpen EH; Van Der Kooy D
    J Comp Neurol; 1996 Feb; 365(4):683-91. PubMed ID: 8742310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of striatal mu1 opiate binding by substantia nigra lesions in the rat.
    Bodnar RJ; Clark JA; Cooper ML; Pasternak GW
    Life Sci; 1988; 43(21):1697-700. PubMed ID: 2848168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of brain lesions on [3H]ohmefentanyl binding site densities in the rat striatum and substantia nigra.
    Masuo Y; Wang H; Pélaprat D; Chi ZQ; Rostène W
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2520-4. PubMed ID: 1332831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early postnatal lesions of the substantia nigra produce massive shrinkage of the rat striatum, disruption of patch neuron distribution, but no loss of patch neurons.
    van der Kooy D
    Brain Res Dev Brain Res; 1996 Jul; 94(2):242-5. PubMed ID: 8836584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disappearance of the mu-opiate receptor patches in the rat neostriatum following lesioning of the ipsilateral nigrostriatal dopamine pathway with 1-methyl-4-phenylpyridinium ion (MPP+): restoration by embryonic nigral dopamine grafts.
    Sirinathsinghji DJ; Dunnett SB
    Brain Res; 1989 Dec; 504(1):115-20. PubMed ID: 2557122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of opioid peptides and receptors in striatum and substantia nigra during rat brain development.
    Winzer-Serhan UH; Chen Y; Leslie FM
    J Chem Neuroanat; 2003 Aug; 26(1):17-36. PubMed ID: 12954528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of striatal compartmentalization following pre- or postnatal dopamine depletion.
    Snyder-Keller AM
    J Neurosci; 1991 Mar; 11(3):810-21. PubMed ID: 1705970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of striatal patch/matrix organization in organotypic co-cultures of perinatal striatum, cortex and substantia nigra.
    Snyder-Keller A; Costantini LC; Graber DJ
    Neuroscience; 2001; 103(1):97-109. PubMed ID: 11311790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neostriatal mosaic. I. Compartmental organization of projections from the striatum to the substantia nigra in the rat.
    Gerfen CR
    J Comp Neurol; 1985 Jun; 236(4):454-76. PubMed ID: 2414339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of opiate receptors and enkephalins in the rat striatum in relationship with the nigrostriatal dopaminergic system: lesion studies.
    Pollard H; Llorens C; Schwartz JC; Gros C; Dray F
    Brain Res; 1978 Aug; 151(2):392-8. PubMed ID: 209865
    [No Abstract]   [Full Text] [Related]  

  • 16. Embryonic substantia nigra grafts innervate embryonic striatal co-grafts in preference to mature host striatum.
    de Beaurepaire R; Freed WJ
    Exp Neurol; 1987 Feb; 95(2):448-54. PubMed ID: 3100320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The localization of receptor binding sites in the substantia nigra and striatum of the rat.
    Reisine TD; Nagy JI; Beaumont K; Fibiger HC; Yamamura HI
    Brain Res; 1979 Nov; 177(2):241-52. PubMed ID: 227532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nigral 6-hydroxydopamine lesions equally decrease mu and delta opiate binding to striatal patches: further evidence for a conformationally malleable type 1 opiate receptor.
    Bowen WD; Pert CB; Pert A
    Life Sci; 1982 Oct 18-25; 31(16-17):1679-82. PubMed ID: 6296571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ontogeny of the D1 dopamine receptor in the rat striatonigral system: an immunohistochemical study.
    Caille I; Dumartin B; Le Moine C; Begueret J; Bloch B
    Eur J Neurosci; 1995 Apr; 7(4):714-22. PubMed ID: 7620620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantia nigra opiate receptors on basal ganglia efferents.
    Ostrowski NL; Pert A
    Brain Res Bull; 1995; 38(6):513-23. PubMed ID: 8590072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.